InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Gharib Samir M., Chief Financial Officer. Director active across 1 company, notably Spruce Biosciences, INC.. In total, 10 filings have been logged. History available since 30 June 2021. The latest transaction was filed on 10 December 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
10 of 10 declarations
Gharib Samir M. serves as Chief Financial Officer and President at Spruce Biosciences, Inc. He is responsible for the company's financial management, including financial planning and risk management. Samir plays a key role in developing financial strategy and communicating financial results to shareholders. His expertise in finance is essential for Spruce Biosciences' growth and sustainability.